Funded Tech Companies

MyoGene Bio

MyoGene Bio is a biopharmaceutical company, based in San Diego. VC investment was provided by CureDuchenne Ventures.

Company Overview

Company Name
MyoGene Bio
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
7098 Miratech Dr 120
San Diego, CA 92121
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Our lead program is a gene editing therapy, MyoDys45-55, for Duchenne muscular dystrophy (DMD), a devastating muscle wasting disease. MyoGene Bio utilizes new technologies to have a strong positive effect on disease progression by targeting the underlying cause of disease. Our company philosophy is to make meaningful impacts on muscle diseases through our dedication to honesty, integrity, and innovation.
Profile
MyoGene Bio LinkedIn Company Profile
Social Media
MyoGene Bio Company Twitter Account
Company News
MyoGene Bio News
Facebook
MyoGene Bio on Facebook
YouTube
MyoGene Bio on YouTube
Last Transaction
5/11/2023

Financing History

Date
Type
Amount
Venture Equity
Unknown


Management Team

Title
Name
Email & Social
Chief Executive Officer
Courtney Young
  Courtney Young LinkedIn Profile  Courtney Young Twitter Account  Courtney Young News  Courtney Young on Facebook
Co-Founder
April Pyle
  April Pyle LinkedIn Profile  April Pyle Twitter Account  April Pyle News  April Pyle on Facebook
Co-Founder
Melissa Spencer
  Melissa Spencer LinkedIn Profile  Melissa Spencer Twitter Account  Melissa Spencer News  Melissa Spencer on Facebook


Company Investors

  • CureDuchenne Ventures

 

 

 

Browse more funded tech companies:

Myocene | MyoKardia

 

Share this article

 


About Our Venture Capital Transactions Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary